RBC Capital analyst Deane Dray lowered the firm’s price target on General Electric to $87 from $93 but keeps an Outperform rating on the shares. The company has smoothly exited "deal purgatory" with its successful spinout of GE Healthcare, and the only blemish on the stock’s investment story continues to be the ongoing operating losses at Renewables, the analyst tells investors in a research note. The firm further notes that the next catalyst for the stock should be the company’s March 9th investor meeting.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GE:
